MesoTV Podcast: Conversations Impacting the Mesothelioma Community

Pain management for mesothelioma patients from a multi-disciplinary perspective

Panel of experts from Baylor College of Medicine discuss pain management for mesothelioma. Moderated by Dr. R. Taylor Ripley, a thoracic surgeon, the panel features Dr. Eugene Choi, a surgeon, who specializes in peritoneal mesothelioma; Dr. Everton Edmondson, a neurologist and pain specialist; and Dr. Ashwin Viswanathan, a neurosurgeon. MesoTV is produced by the Mesothelioma Applied Research Foundation, a nonprofit organization dedicated to eradicating mesothelioma as a life-ending cancer. The organization funds peer-reviewed research; provide patient support services and education; and advocates for research funding. More information is available at www.curemeso.org.

Discussion of mesothelioma patients who underwent an EPP (extrapleural pneumonectomy - lung removal)

Moderated by Dr. Daniel Sterman, NYU Langone's Director of the Division of Pulmonary, Critical Care and Sleep Medicine and Director of the Multidisciplinary Pulmonary Oncology Program, this episode features a panel of patients who  underwent an EPP (extrapleural pneumonectomy - lung removal) who discuss their experiences and side-effects prior to surgery, immediately after surgery, and long term.

Clinical trial assessing the addition of IMRT to pemetrexed (Alimta)/platinum based therapy

Dr. Andreas Rimner of Memorial Sloan Kettering Cancer Center joins us to discuss a clinical trial "Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma." Dr. Rimner is a radiation oncologist specializing in thoracic cancers. He in interviewed by Mary Hesdorffer, expert nurse practitioner and executive director of the Mesothelioma Applied Research Foundation. Patients who need help with their diagnosis can contact Mary Hesdorffer, NP through the organization's website. The Mesothelioma Applied Research Foundation is the only national nonprofit organization dedicated to eradicating mesothelioma by providing patient services and education; funding peer-reviewed research; and advocating for government funding of mesothelioma research. More information about the organization is available at www.curemeso.org.

Vaccination Considerations for Mesothelioma Patients

Dr. Sean Drake, of the Henry Ford Medical System in Detroit, Michigan, takes some time to talk to us and discuss immunizations recommended for cancer patients, and mesothelioma patients specifically. Learn more at www.curemeso.org/mesotv.

Dr. Paul Sugarbaker discusses HIPEC in peritoneal mesothelioma

Dr. Paul Sugarbaker joined us for an interview about HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal mesothelioma.

Paul Sugarbaker, MD, FACS, FRCS, is the Chief of the Peritoneal Surface Malignancy Program and the Director of the Center for Gastrointestinal Malignancies at the Washington Hospital Center in Washington, DC.

MesoTV is the Mesothelioma Applied Research Foundation’s recorded series covering pertinent conversations impacting the mesothelioma community. You can learn more at curemeso.org/mesotv.

The Mesothelioma Applied Research Foundation is the only nonprofit charity organization dedicated to ending mesothelioma, and the suffering caused by this cancer, by:

• funding research to improve treatment options;
• providing treatment support and education for patients and their families;
• and advocating for federal funding of research.

 

Mesothelioma Patients Discuss "Chemo Brain"

Three mesothelioma patients share their experiences with cancer-related cognitive impairment — also known as "chemo brain" — with Dr. Tracy Vannorsdall, a neuropsychologist at the Johns Hopkins University School of Medicine. Moderated by Mary Hesdorffer, NP, executive director of the Mesothelioma Applied Research Foundation. Subscribe for alerts. More information at https://www.curemeso.org/mesotv.

Inherited Genetics and Mesothelioma

Jane Churpek, MD, MS, discusses inherited genetics and mesothelioma, in particular as they relate to the BAP1 gene and the BRCA2. Specifically, she covers how cancer prevention and selection of effective treatment options for mesothelioma patients both rely on an understanding of genetic changes.

Life After Mesothelioma Treatment Community Panel

Heather Von St James, Jill Waite, Rich Mosca, Liam Bradley, John Panza, and Sara Babin discuss their own experiences with mesothelioma and how their lives have changed post-treatment. Subscribe for alerts. More information at https://www.curemeso.org/mesotv.

FDA's Expanded Access and Compassionate Use Rules' Impact on Mesothelioma Treatment

Adnan Jaigirdar, MD, FACS, provided an overview of the U.S. Food and Drug Administration (FDA) expanded access program (compassionate use) for investigative therapies for mesothelioma patients.